Tag: NSCLC
Bristol Myers: failed trial in NSCLC
(CercleFinance.com) – Bristol Myers Squibb announces that the Phase 3 CheckMate-73L trial did not meet its primary endpoint of progression-free survival in non-small cell lung cancer (NSCLC) unresectable and locally…
Bristol Myers: Failed trial in NSCLC
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Merck: favorable opinion from the CHMP for Keytruda in NSCLC
(CercleFinance.com) – Merck announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has given a positive opinion recommending the approval of Keytruda…